The report provides a granular understanding of the glycomics enzymes, instruments, kits and reagents market. This report segments the global glycomics market on the basis of applications, end users, products and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications.
Dallas, TX -- (SBWIRE) -- 11/21/2014 -- According to the new market research report the “Glycobiology / Glycomics Market (Enzymes, Instruments, Kits, and Reagents), Application (Immunology, Oncology), Product (Glycosyltransferase, Neuraminidase, Glycosidase, HPLC, Mass Spectrometry, MALDI-TOF), End User - Global Forecast to 2019 ”, published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global glycomics enzymes, instruments, kits and reagents market along with the estimates and forecasts of the revenue and market share analysis.
Browse 76 market tables and 115 figures spread through 214 pages on "Glycobiology / Glycomics Market"
http://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html
Early buyers will receive 10% customization on this report.
The global Glycomics Market was valued at $512.38 Million in 2014. This market is expected to grow at a CAGR of 12.62% to reach $928.11 Million in 2019.
The global Glycomics Market is segmented on the basis of applications, end users and products. By application, the market is divided into diagnostics; drug discovery and development; immunology; oncology, and other applications. Of these, the drug discovery and development applications segment accounted for the largest share of the global glycomics enzymes, instruments, kits and reagents market in 2014. The end-user segments included in this report are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies .By products, the market is segmented into enzymes, instruments, kits, and reagents.
Further Inquiry:
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=132685525
The enzymes product segment is further subsegmented into glycosidases; glycosyl transferases; neuraminidases; sialyltransferases; and other enzymes. Of these, the glycosidases subsegment held the largest share of the global glycomics enzymes market in 2014, and is poised to grow at the highest CAGR between 2012 and 2019. The instrument segment is further subsegmented into antibody arrays; High-Performance Liquid Chromatography (HPLC); lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments. The kits product segment is further subsegmented into glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits. The reagents segment is further subsegmented into glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents.
Buy Now:
http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=132685525
The geographic segments included in this report are Asia, Europe, North America, and Rest of the World (RoW).The Asian segment is further divided into China, India, Japan, and Rest of Asia. Europe is divided into France, Germany, Italy, Spain, the U.K., and Rest of Europe. North America includes Canada, and the U.S. RoW encompasses the Middle East and Africa, Pacific and Oceania, and South America.
An increase in R&D expenditure by pharmaceutical and biotech companies and government support for the biotechnology industry will be the two most important growth drivers for this market in the forecast period (2012–2019). For instance, the Chinese government increased its basic research investment by 26% from 2011 to 2012 and decided to put more than $300 billion into biotechnology between 2012 and 2017. Investments of this nature will aid the growth of the glycomics market.
The major players in the Glycomics Market are Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme, Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.), among others.
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com